T-cell-receptor engagement and tumor ICAM-1 up-regulation are required to by-pass low susceptibility of melanoma cells to autologous CTL-mediated lysis-Reference-Cited by-同舟云学术

T-cell-receptor engagement and tumor ICAM-1 up-regulation are required to by-pass low susceptibility of melanoma cells to autologous CTL-mediated lysis

Published:2009-10-13 Issue:6 Volume:53 Page:994-1001
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Anichini Andrea,Mortarini Roberta,Parmiani Giorgio,Alberti Saverio,Mantovani Alberto

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference23 articles.

1. Distinct forms of both α and β subunits are present in human Ia molecular pool;Accolla;Proc. Nat. Acad. Sci. (Wash.),1981

2. Cytotoxic T lymphocyte clones from peripheral blood and from tumor site detect intratumor heterogeneity of melanoma cells. Analysis of specificity and mechanisms of interaction;Anichini;J. Immunol.,1989

3. β1 Integrins on melanoma clones regulate the interaction with autologous cytotoxic T cell clones;Anichini;J. Immunother.,1992

4. Human melanoma cells with high susceptibility to cell-mediated lysis can be identified on the basis of ICAM-1 phenotype, VLA profile and invasive ability;Anichini;Int. J. Cancer,1990

5. ICAM-1− melanoma cells are relatively resistant to CD3-mediated T-cell lysis;Braakman;Int. J. Cancer,1990

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alloreactive Effector T Cells Require the Local Formation of a Proinflammatory Environment to Allow Crosstalk and High Avidity Interaction with Nonhematopoietic Tissues to Induce GVHD Reactivity;Biology of Blood and Marrow Transplantation;2012-09

2. GAMMA-RADIATION UPREGULATES MHC CLASS I/II AND ICAM-I MOLECULES IN MULTIPLE MYELOMA CELL LINES AND PRIMARY TUMORS;In Vitro Cellular & Developmental Biology - Animal;2006

3. Amplification of the lytic potential of effector/memory CD8+ cells by vector-based enhancement of ICAM-1 (CD54) in target cells: implications for intratumoral vaccine therapy;Cancer Gene Therapy;2004-09-03

4. Regulation of CD43-induced U937 homotypic aggregation;Experimental Cell Research;2003-10

5. Presentation of native TROP-2 tumor antigens to human cytotoxic T lymphocytes by engineered antigen-presenting cells;International Journal of Cancer;2002-09-03